First Time Loading...

Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 1.405 USD -3.1% Market Closed
Updated: Jun 10, 2024

Spero Therapeutics Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Spero Therapeutics Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Spero Therapeutics Inc
NASDAQ:SPRO
Other Current Liabilities
$31.7m
CAGR 3-Years
N/A
CAGR 5-Years
175%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.3B
CAGR 3-Years
149%
CAGR 5-Years
406%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$648.6m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$516.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%

See Also

What is Spero Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
31.7m USD

Based on the financial report for Mar 31, 2024, Spero Therapeutics Inc's Other Current Liabilities amounts to 31.7m USD.

What is Spero Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
175%

Over the last year, the Other Current Liabilities growth was 168%.